Cranbrook Wealth Management’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,816
Closed -$113K 395
2025
Q4
$113K Hold
15,816
0.02% 156
2025
Q3
$119K Hold
15,816
0.02% 153
2025
Q2
$98.7K Hold
15,816
0.02% 162
2025
Q1
$49.3K Hold
15,816
0.01% 185
2024
Q4
$62.5K Hold
15,816
0.01% 177
2024
Q3
$64.1K Hold
15,816
0.01% 172
2024
Q2
$40.3K Hold
15,816
0.01% 192
2024
Q1
$70.4K Hold
15,816
0.02% 142
2023
Q4
$74.7K Sell
15,816
-4,184
-21% -$17.9K 0.02% 138
2023
Q3
$97.2K Hold
20,000
0.03% 119
2023
Q2
$120K Hold
20,000
0.03% 112
2023
Q1
$62.4K Hold
20,000
0.02% 142
2022
Q4
$51.8K Hold
20,000
0.01% 155
2022
Q3
$42K Buy
+20,000
New +$52.2K 0.01% 177

Other funds holding EVLV

Cranbrook Wealth Management's EVLV Position: Q1 2026 in Review

Cranbrook Wealth Management sold out of Evolv Technologies (EVLV) in Q1 2026, closing a stake of 15,816 shares — an estimated $113K sold.

Cranbrook Wealth Management first reported a position in EVLV in Q3 2022 and held it in 14 quarters. The position peaked at $120K in Q2 2023. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Cranbrook Wealth Management reported no remaining Evolv Technologies position as of Q1 2026 after selling out during the quarter.
  • Cranbrook Wealth Management sold 15,816 Evolv Technologies shares in Q1 2026, an estimated $113K.
  • Cranbrook Wealth Management first reported a position in Evolv Technologies in Q3 2022 and held it in 14 quarters.
  • Cranbrook Wealth Management's Evolv Technologies position peaked at $120K in Q2 2023.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.